SCHEMBL6707786

SCHEMBL6707786

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)Cc4ccc(Cl)cc4Cl)c3[nH]2)c(-c2nnn[nH]2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GALR3 O60755 1/20 0.36
NR2F2 P24468 1/20 0.36
LMNA P02545 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
PARP14 Q460N5 2/20 0.34
NHERF1 O14745 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RORC P51449 1/20 0.33
MAPT P10636 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
IDO1 P14902 1/20 0.32
PLCG2 P16885 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708617 0.93 PARP14 (0.41) LMNAALDH1A1HPGDKDM4EPARP14
SCHEMBL6710475 0.93 GALR3 (0.40) GALR3NR2F2LMNAALDH1A1HPGD
SCHEMBL6712091 0.90 PARP14 (0.39) LMNAALDH1A1KDM4EPARP14MEN1
SCHEMBL6707760 0.90 PARP14 (0.41) LMNAALDH1A1PARP14MEN1KMT2A
SCHEMBL6713271 0.90 PARP14 (0.36) LMNAPARP14MEN1KMT2AMAPT
SCHEMBL6711546 0.89 GALR3 (0.37) GALR3NR2F2LMNAALDH1A1HPGD
SCHEMBL6711435 0.88 PARP14 (0.42) LMNAKDM4EPARP14MEN1KMT2A
SCHEMBL6708924 0.87 ALDH1A1 (0.41) LMNAALDH1A1HPGDKDM4EPARP14
SCHEMBL6708676 0.87 PARP14 (0.43) GALR3NR2F2LMNAALDH1A1KDM4E
SCHEMBL6711981 0.87 ALDH1A1 (0.39) LMNAALDH1A1HPGDKDM4EPARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GALR3 4874/4885NR2F2 1512/4885LMNA 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.